The effect of 2-halogenoalkylamines on the biological activity of some peptides.
D000109:Acetylcholine / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000494:pharmacology*; D001966:Bromine / Q000494:pharmacology*; D003983:Dibenzylchlorethamine / Q000494:pharmacology*; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology*
D000605:Amino Alcohols; D006634:Histamine H1 Antagonists; D010627:Phenethylamines; D013565:Sympatholytics; D014667:Vasopressins; D000804:Angiotensin II; D003983:Dibenzylchlorethamine; D010121:Oxytocin; D006632:Histamine; D009074:Melanocyte-Stimulating Hormones; D001120:Arginine; D000109:Acetylcholine; D001920:Bradykinin; D001966:Bromine; D009638:Norepinephrine